Influence
June 20, 2025

Rectal location and postcolonoscopy colorectal cancer outcomes

Thomas Imperiale

Published in the JAMA Network Open. Here is a link to the article.

Regenstrief Institute authors: Thomas Imperiale, M.D.

This study examines the relationship between the anatomical location of postcolonoscopy colorectal cancers (PCCRCs) and patient mortality outcomes within the Veterans Health Administration (VHA) system. PCCRCs are cancers identified 6 to 36 months after a colonoscopy that failed to detect malignancy, and they are a key quality indicator of colonoscopy performance. While PCCRCs are commonly associated with the proximal colon, recent evidence highlights a notable incidence in the rectum—a region with distinct biological behavior and a tendency for local invasion.

Using VHA-Medicare data from 2003 to 2013, researchers identified 5,248 cases of rectal cancer and compared all-cause mortality (ACM) and cancer-specific mortality (CSM) between rectal PCCRCs and cancers detected within six months of colonoscopy (DCRC). Advanced statistical analyses, including Cox proportional hazards models, revealed no significant differences in ACM or CSM between rectal PCCRCs and rectal DCRCs. Similar comparisons between rectal and right colon PCCRCs yielded no statistically meaningful differences. A modest but statistically significant mortality difference was found when comparing rectal DCRCs to right colon DCRCs.

The findings suggest that rectal location and the PCCRC classification do not substantially impact mortality outcomes. However, limitations such as missing data on patient health factors and potential underreporting of non-VHA colonoscopies warrant cautious interpretation. This study reinforces the need for thorough inspection of the rectum during colonoscopy, as it remains a common site for missed cancers. Further investigation is recommended to understand contributing factors and improve detection strategies.

Authors: 

Charles J. Kahi, MD, MSc1,2,3Laura J. Myers, PhD2,3,5Patrick O. Monahan, PhD4Barry C. Barker, MA3Timothy E. Stump, MA3,4Thomas F. Imperiale, MD1,2,3,5

Affiliations: 

1Department of Medicine, Richard L. Roudebush VA Medical Center, Indianapolis, Indiana
2Health Services Research & Development, Richard L. Roudebush VA Medical Center, Indianapolis, Indiana
3Indiana University School of Medicine, Indianapolis
4Department of Biostatistics and Health Data Science, Indiana University School of Medicine, Indianapolis
5The Regenstrief Institute, Indianapolis, Indiana

Partners

Related News

Regenstrief Institute and Suki partner to evaluate ambient AI in healthcare

Organizations share a commitment to understanding how ambient AI technologies impact clinicians, patients and healthcare delivery  Regenstrief Institute and Suki, a

Dr. Peter J. Embi

Regenstrief’s legacy with the National Library of Medicine continues

Peter J. Embí, M.D., M.S., former president and CEO of the Regenstrief Institute, has been appointed director of the

image showing two people connecting through a kidney

Regenstrief Institute awarded KidneyX prize to advance living kidney donation

LIVINGkidney digital tool recognized in national HHS competition focused on reducing barriers for living kidney donors and transplant patients  Regenstrief

LOINC® version 2.83 enhances global health data exchange through new terminology and implementation improvements

Release expands terminology for drug and toxicology testing, microbiology, public health reporting and allergy information Regenstrief Institute has released